Mary Collins

11.3k total citations · 1 hit paper
184 papers, 9.5k citations indexed

About

Mary Collins is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Mary Collins has authored 184 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 78 papers in Immunology and 66 papers in Genetics. Recurrent topics in Mary Collins's work include Virus-based gene therapy research (66 papers), Immunotherapy and Immune Responses (41 papers) and RNA Interference and Gene Delivery (31 papers). Mary Collins is often cited by papers focused on Virus-based gene therapy research (66 papers), Immunotherapy and Immune Responses (41 papers) and RNA Interference and Gene Delivery (31 papers). Mary Collins collaborates with scholars based in United Kingdom, United States and Spain. Mary Collins's co-authors include Yasuhiro Takeuchi, Abelardo López‐Rivas, Enrique Rozengurt, François–Loïc Cosset, Robin A. Weiss, Gemma Rodríguez‐Tarduchy, Jean‐Luc Battini, Yasuhiro Ikeda, Stephen J. Russell and Gordon R. Perkins and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Mary Collins

181 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-titer packaging cells producing recombinant retroviruses resistant to human serum

1995 587 citations François–Loïc Cosset, Yasuhiro Takeuchi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Collins United Kingdom	55	5.2k	3.2k	2.7k	2.1k	1.1k	184	9.5k
Michael Eckhaus United States	47	4.8k 0.9×	1.4k 0.4×	2.0k 0.7×	1.5k 0.7×	1.3k 1.1×	114	10.2k
Mamoru Ito Japan	53	3.0k 0.6×	1.3k 0.4×	4.1k 1.5×	1.9k 0.9×	895 0.8×	220	10.0k
Bruce E. Torbett United States	46	3.5k 0.7×	1.5k 0.5×	3.0k 1.1×	1.1k 0.5×	746 0.7×	143	8.0k
Richard Tizard United States	41	6.1k 1.2×	1.7k 0.5×	3.3k 1.2×	847 0.4×	670 0.6×	56	11.8k
Kumao Toyoshima Japan	43	5.1k 1.0×	1.3k 0.4×	2.4k 0.9×	3.3k 1.6×	815 0.7×	128	10.0k
Michel L. Tremblay Canada	71	10.4k 2.0×	1.5k 0.5×	5.6k 2.0×	2.3k 1.1×	1.3k 1.1×	270	15.7k
Zwi Berneman Belgium	53	4.8k 0.9×	1.3k 0.4×	4.6k 1.7×	3.7k 1.8×	1.1k 1.0×	320	13.2k
W. Gregory Alvord United States	43	3.3k 0.6×	883 0.3×	2.5k 0.9×	1.3k 0.6×	1.5k 1.3×	122	8.4k
Arthur W. Nienhuis United States	72	8.4k 1.6×	4.9k 1.6×	1.5k 0.6×	2.4k 1.1×	679 0.6×	255	15.8k
Barry P. Sleckman United States	51	5.3k 1.0×	890 0.3×	4.6k 1.7×	2.2k 1.0×	1.3k 1.1×	137	10.0k

Countries citing papers authored by Mary Collins

Since Specialization

Citations

This map shows the geographic impact of Mary Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Collins more than expected).

Fields of papers citing papers by Mary Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Collins. The network helps show where Mary Collins may publish in the future.

Co-authorship network of co-authors of Mary Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Collins. A scholar is included among the top collaborators of Mary Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Collins. Mary Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bagnéris, Claire, et al.. (2022). Mechanistic insights into the activation of the IKK kinase complex by the Kaposi’s sarcoma herpes virus oncoprotein vFLIP. Journal of Biological Chemistry. 298(6). 102012–102012. 6 indexed citations

Bricogne, Christopher, Michael Fine, Pedro M. Pereira, et al.. (2019). TMEM16F activation by Ca2+ triggers plasma membrane expansion and directs PD-1 trafficking. Scientific Reports. 9(1). 47 indexed citations

Sanber, Khaled, Sean Knight, Sam L. Stephen, et al.. (2015). Construction of stable packaging cell lines for clinical lentiviral vector production. Scientific Reports. 5(1). 9021–9021. 76 indexed citations

MacDonald, Douglas, Harsimran Singh, Mike Whelan, et al.. (2013). Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease. Mucosal Immunology. 7(1). 89–100. 18 indexed citations

Phillips, Sarah, Mary Collins, & Lisa Dougherty. (2011). Venepuncture and cannulation. Wiley-Blackwell eBooks. 7 indexed citations

Arce, Frederick, Karine Breckpot, Holly Stephenson, et al.. (2010). Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen‐specific regulatory T cells, and suppresses experimental inflammatory arthritis. Arthritis & Rheumatism. 63(1). 84–95. 54 indexed citations

Arce, Frederick, Karine Breckpot, Holly Stephenson, et al.. (2010). Selective ERK activation suppresses inflammatory arthritis via tolerogenic dendritic cells and antigen-specific regulatory T cells. VUBIR (Vrije Universiteit Brussel). 273–273. 2 indexed citations

Buchholz, Christian J., et al.. (2010). Lentiviral Vectors Targeted to MHC II Are Effective in Immunization. Human Gene Therapy. 22(10). 1249–1254. 29 indexed citations

Collins, Mary. (2006). Conscience clauses and oral contraceptives: conscientious objection or calculated obstruction?. PubMed. 15(1). 37–60, table of contents. 2 indexed citations

10.

Palmowski, Michael J., Luciene Lopes, Yasuhiro Ikeda, et al.. (2004). Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response. The Journal of Immunology. 172(3). 1582–1587. 87 indexed citations

11.

Collins, Mary. (2001). Conference Report. The Australian Journal of Hospital Pharmacy. 31(1). 57–67.

12.

Low, Walter C., Anna Smith, Alan Ashworth, & Mary Collins. (1999). JNK activation is not required for Fas-mediated apoptosis. Oncogene. 18(25). 3737–3741. 28 indexed citations

13.

López‐Rivas, Abelardo, et al.. (1998). Induction of apoptosis by valinomycin: mitochondrial permeability transition causes intracellular acidification. Cell Death and Differentiation. 5(3). 214–221. 78 indexed citations

14.

Bridgewater, John, R.J. Knox, J. D. Pitts, Mary Collins, & Caroline J. Springer. (1997). The Bystander Effect of the Nitroreductase/CB 1954 Enzyme/Prodrug System Is Due to a Cell-Permeable Metabolite. Human Gene Therapy. 8(6). 709–717. 108 indexed citations

15.

Smith, Anna, Francisco Ramos‐Morales, Alan Ashworth, & Mary Collins. (1997). A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells. Current Biology. 7(11). 893–896. 67 indexed citations

16.

Collins, Mary, Chetankumar S. Tailor, Mohamed Parkar, et al.. (1996). Comparison of Efficiency of Infection of Human Gene Therapy Target Cells via Four Different Retroviral Receptors. Human Gene Therapy. 7(8). 913–919. 64 indexed citations

17.

Collins, Mary. (1995). Potential Roles of Apoptosis in Viral Pathogenesis. American Journal of Respiratory and Critical Care Medicine. 152(4_Part_2). S20–S24. 43 indexed citations

18.

Gore, Martin & Mary Collins. (1994). Gene therapy for cancer. European Journal of Cancer. 30(8). 1047–1049. 11 indexed citations

19.

Perkins, Gordon R., Claudia L. Flemming, David Kabat, & Mary Collins. (1993). The role of IL-2 interaction with p75 and p55 receptor molecules in the stimulation of cell proliferation. International Immunology. 5(5). 541–549. 2 indexed citations

20.

Russell, Stephen J., Suzanne A. Eccles, Claudia L. Flemming, Caroline A. Johnson, & Mary Collins. (1991). Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL‐2 cDNA. International Journal of Cancer. 47(2). 244–251. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact